Please provide your email address to receive an email when new articles are posted on . BOSTON — Statin therapy appears to be most effective in the prevention of new-onset atrial fibrillation in ...
The CHADS2 stroke risk scores 0 or 1 assign more than one-third of patients in atrial fibrillation with stroke to low or intermediate risk not mandating oral anticoagulation, according to new research ...
Dr. Hugh Calkins answers the question: 'Blood Thinners And Atrial Fibrillation?' — -- Question: When are blood thinners necessary in treating atrial fibrillation, and what are the risks? Answer ...
A CHA2DS2-VASc score of 0 identifies a subgroup of patients with very low stroke risk unlikely to benefit from anticoagulation treatment in contrast. Professor Nabauer said: "AF is the most frequent ...
More than a quarter of atrial fibrillation patients with a CHADS2 score of one could be reclassified as truly low risk and not given anticoagulation, a new study suggests. Under current guidance, ...
The CHADS 2 (Congestive heart failure, Hypertension, Age ≥75, Diabetes, Stroke history [2 points]) risk score for stroke was validated in patients with atrial fibrillation (AF) who were not treated ...
A 57-year-old man presents with palpitations and a rapid, irregular heartbeat accompanied by breathlessness and fatigue. These symptoms began the prior evening, are ongoing and have occurred off and ...
The earlier that patients who suffer from atrial fibrillation obtain the correct treatment, the lower is the risk of serious secondary effects such as stroke. New research from Sweden shows that a ...
The CHADS 2 tool is easy to remember and if the patient scores 1 or more then they should be considered at moderate or high stroke risk. In those who score less than 2 then the CHA 2 DS 2 VASc tool ...
Expert Rev Cardiovasc Ther. 2012;10(4):433-439. This article suggests the need to reconsider the benefits of using aspirin in stroke prevention, especially in low-risk patients or patients not ...
In contrast, a CHA2DS2-VASc score of 0 identifies a subgroup of patients with very low stroke risk unlikely to benefit from anticoagulation treatment. Professor Nabauer said: "AF is the most frequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results